E-LIB Suche - Ergebnisse für: Camidge, DR

Camidge, DR ; Kim, HR ; Ahn, M-J...
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2021. , 2021

Link: https://repository.icr.a..

9

Health-related quality of life in the randomized phase III ..:

Garcia Campelo, MR ; Lin, HM ; Zhu, Y...
Lung cancer (Amsterdam, Netherlands), 2021, 155 pp. 68 - 77. , 2021

Link: https://repository.icr.a..

10

Intracranial and extracranial efficacy of lorlatinib in pat..:

Felip, E ; Shaw, AT ; Bearz, A...
issn:0923-7534. , 2021

Link: http://hdl.handle.net/11..

11

Brigatinib versus crizotinib in advanced ALK inhibitor-naiv..:

Camidge, DR ; Kim, HR ; Ahn, M-J...
Journal of Clinical Oncology. , 2020

Link: http://hdl.handle.net/10..

12

Crizotinib in ROS1-rearranged advanced non-small-cell lung ..:

Shaw, AT ; Riely, GJ ; Bang, Y-J...
issn:0923-7534. , 2019

Link: http://hdl.handle.net/11..

13

Immune checkpoint inhibitors for patients with advanced lun..:

Mazieres, J ; Drilon, A ; Lusque, A...
qt76g4v3qj. , 2019

Link: https://escholarship.org..

14

Immune checkpoint inhibitors for patients with advanced lun..:

Mazieres, J ; Drilon, A ; Lusque, A...
issn:0923-7534. , 2019

Link: http://hdl.handle.net/11..

15

Immune checkpoint inhibitors for patients with advanced lun..:

Mazieres, J ; Drilon, A ; Lusque, A...
Annals of oncology : official journal of the European Society for Medical Oncology, 2019, 30 (8), pp. 1321 - 1328. , 2019

Link: https://repository.icr.a..